Literature DB >> 7237052

Evaluation of computed tomography in the management of testicular teratoma.

J E Husband, A Barrett, M J Peckham.   

Abstract

An analysis has been made of data obtained by computed tomography (CT) scanning in 100 patients with testicular teratoma. The results have been compared with information obtained by conventional staging procedures and changes in patient management occurring as a direct result of CT have been noted. Although these tumours are rare, their pattern of metastasis to the retroperitoneum, mediastinum, lungs and liver is consistent. Thus the value of CT scanning can be tested in all of these sites in each patient and the indications for scanning clearly defined.

Entities:  

Mesh:

Year:  1981        PMID: 7237052     DOI: 10.1111/j.1464-410x.1981.tb03162.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

Review 1.  Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes.

Authors:  G C Dooms; H Hricak
Journal:  West J Med       Date:  1986-01

Review 2.  Modern Diagnostic Imaging Technique Applications and Risk Factors in the Medical Field: A Review.

Authors:  Shah Hussain; Iqra Mubeen; Niamat Ullah; Syed Shahab Ud Din Shah; Bakhtawar Abduljalil Khan; Muhammad Zahoor; Riaz Ullah; Farhat Ali Khan; Mujeeb A Sultan
Journal:  Biomed Res Int       Date:  2022-06-06       Impact factor: 3.246

3.  A contribution to the treatment of non-seminomatous testicular tumours.

Authors:  J Base; P Navrátil
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

Review 4.  Lung metastases.

Authors:  C J Herold; A A Bankier; D Fleischmann
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 5.  The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor.

Authors:  Timothy A Masterson; Clint Cary
Journal:  Adv Urol       Date:  2018-04-05

6.  Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.

Authors:  D Raghavan; M J Peckham; E Heyderman; J S Tobias; D E Austin
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.